Markets › India › NSE › AARTIPHARM

Aarti Pharmalabs Ltd

NSE:AARTIPHARMHealthcareNSE:NIFTY_MICROCAP250NSE:NIFTY_TOTAL_MKT

₹832.35−4.73%At closeAt close · Mon 19 Oct · ≈ AED 32.11 · Market cap $783.42M

INR billions	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	YoY
Net income	(0.0)	1.6	2.6	2.2	2.7	2.3	−16.4%
Depreciation & amortization	0.0	0.4	0.6	0.7	0.9	1.0	+20.1%
Stock-based compensation	0.0	0.0	0.0	0.0	0.0	0.0	—
Change in working capital	0.0	(1.6)	(0.3)	(1.7)	(0.3)	(1.1)	−266.9%
Operating cash flow	0.0	(0.4)	2.5	2.2	3.3	2.6	−21.0%
Capital expenditure	0.0	(1.4)	(1.2)	(2.0)	(4.0)	(4.5)	−11.5%
Acquisitions	0.0	0.0	0.0	0.0	0.0	0.0	—
Investing cash flow	0.0	(1.4)	(1.6)	(2.1)	(4.1)	(4.3)	−4.1%
Dividends paid	0.0	0.0	(0.2)	(0.2)	(0.3)	(0.4)	−14.3%
Share buybacks	0.0	0.0	0.0	0.0	0.0	0.0	—
Debt issued / repaid	0.0	2.7	(1.2)	0.5	1.3	2.6	+106.7%
Financing cash flow	0.0	2.6	(1.6)	0.1	0.7	1.7	+160.7%
Free cash flow	0.0	(1.8)	1.3	0.2	(0.7)	(1.9)	−164.5%
Net change in cash	0.0	0.8	(0.7)	0.1	(0.2)	0.0	+110.6%